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Abstract I propose an alternative model of cancer in which metastasis need not all arise out
of spread from the ‘‘original’’ tumour. The model assumes that cancer cells arise from stem
cells that best grow in the organ of their differentiation. When the internal milieu allows it
they also grow at other sites as well, thus complementing the conventional (spreading) meta-
static process. Several phenomena in the natural history of cancer, especially breast cancer,
that challenge the conventional model, fit well after inclusion of the new model. These are
(a) a very modest benefit of screening (b) frequent sparing of lungs from haematogenous me-
tastasis (c) presence of occult cancers in autopsy studies (d) only a modest effect of local
treatment (e) relative ineffectiveness of high-dose chemotherapy (f) constant time between
surgery and peak of hazard of relapse irrespective of stage of the tumour. All these phenomena
are much easier to explain when one rejects the dogma that all metastasis arise only from the
primary tumour. This paper is aimed only to suggest an alternative perspective of natural his-
tory of solid tumours e to stimulate research on the complex internal milieu that allows cancer
cells to develop in new light.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.The conventional model of cancer cell growth and
metastasis is the following1: cancer arises from a fault in
a cell. This single faulty cell then multiplies to form a cluster
of cells e a tumour. Tumour cells then spread to the whole
body and these metastases can eventually kill the person.
I propose an alternative model. When the internal milieu
of a person is disturbed, stem cells from all parts of the
body can grow into tumours. This disturbance in the milieu
may be mild or severe. The complex change in the milieu
favours development of one type of differentiation of these
tumours, for example, breast epithelial cells. The best
tissue environment for a breast epithelial cell is the breast.
So, the breast cancer stem cell in the breast grows the
fastest and therefore is clinically apparent first, or when
the internal milieu is only mildly disturbed. Severe distur-
bance of the internal milieu results in growth of breast1743-9191/$ - see front matter ª 2006 Surgical Associates Ltd. Pub
doi:10.1016/j.ijsu.2006.06.003cancer stem cells all over the body e clinically presenting
as metastasis.
In reality, metastasis could be explained by both models
each contributing to the whole picture, such that a propor-
tion of systemic cancer foci could be arising from migration
of cells from the larger tumour in the organ of its prefer-
ence and a proportion ‘‘home-grown’’ at that site. This pro-
portion could be different for different types of tumours.
Predictions from the alternative model would be the
following:
Risk of a cancer would depend on number and sensitivity of
stem cells in the body.
Removal of the ‘‘primary’’ tumour should not affect the
ultimate outcome, unless the act of surgical excision itself
disturbs the internal milieu (favourably or unfavourably).lished by Elsevier Ltd. All rights reserved.
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after removal of the ‘‘primary’’.
Metastasis could arise in any part of the body, unrelated to
the path which the cancer cell may take from the primary
tumour to the site of metastasis; and this could also explain
metastasis with ‘‘unknown primary’’.
Several phenomena that appear to be paradoxes in the
conventional model are not paradoxical in the alternative
model. Each of these could also be considered as natural
experiments/phenomenon that failed to falsify the new
hypothesis.
(1) If the ‘‘primary’’ breast cancer were the sole source of
metastasis then earlier removal of the ‘‘primary’’ e by
screening e should have resulted in a huge reduction in
appearance of metastatic disease and mortality. Unfor-
tunately screening mammography which manages to
allow treatment of smaller and earlier cancers in the
breast reduces mortality by only modest level.2 In the
alternative model, when a small tumour is found in
the breast e it is only incidental and could be the result
of only a mildly disturbed milieu that would never allow
the stem cells from rest of the body to grow so its re-
moval may not have the expected impact. The impact
will depend on how disturbed the milieu is and how
much contribution the conventional spreading is making
to the ultimate outcome. Thus the new strategy could
also explain the difference in benefit from screening
between different tumour types (for example, none in
lung or prostate but modest in colon) or between age
groups (for example, much higher benefit from screen-
ing mammography in those >50 vs. <50)? Taking the
latter example, we should first remember that overall
far fewer younger women die of breast cancer. Of
course, those that are diagnosed do much worse e for
in order to be diagnosed with cancer they had to have
far higher disturbance in their internal milieu than
older women. The benefit from earlier diagnosis like-
wise will be less perhaps because the milieu plays
much more important part in their disease than in older
women. The latter argument would explain the differ-
ential benefits of screening for different tumours.
(2) One third of women of age 50e55 years harbour occult
cancers in their breasts3 e this is never the incidence of
clinical tumours. Being above the size that require vas-
cularity to survive, these should have all given rise to
metastasis and be fatal. However, without severe dis-
turbance of the internal milieu none of these, or those
in rest of the body would grow. On the other hand one
could argue the reverse that these occult tumours
themselves are biologically inert. It is like arguing
whether this is written in blank in over white paper or
with white ink covering almost all of black paper. It
should be noted, however, that we have not been
able to yet identify a single biological or morphological
factor that can identify such ‘‘inert’’ cancers that
would have not progressed and become clinically dan-
gerous. The benefit from diagnosing these ‘‘cancers’’
early is perhaps overshadowed by the possible harm
from disturbing the milieu of these women by interven-
tion such as surgical excision stimulating angiogenesis.(3) Following the venous drainage tumour cells need to
move from the breast or almost any other organ, to
the lungs first and thence to rest of the body.4
Thus lung metastasis should be the most common
metastasis e but that is not often the case e bone or
brain metastasis can arise in the absence of lung metas-
tasis. This can be easily explained by the alternative
model which does not require the ‘‘travel’’ from the
‘‘primary’’ to the metastatic site. The stem cells from
the metastatic site grow into ‘‘breast’’ tumours in the
internal milieu and favours differentiation into mam-
mary adenocarcinoma. It is plausible that certain envi-
ronments are more abundant in or more conducive to
growth of stem cells such as bone marrow as opposed
to muscle tissue.
(4) Some cancers such as basal cell carcinomas never ‘‘give
rise’’ to systemic metastases e except in presence of
immunosuppresion with AIDS.5 Some others rarely do
such as squamous carcinomas of head and neck. The
milieu in rest of the body is probably not conducive to
growth of squamous carcinoma that may require expo-
sure to atmosphere (including lung and gastrointestinal
tract).
(5) Longer exposure to a faulty milieu should give rise to
more cancer e this fits with the increasing incidence
and mortality from cancer with age.
(6) The effect of local treatment of breast cancer on ulti-
mate outcome is not 100%. The rate of reduction in
mortality is only a fifth of the reduction in reduction
of local recurrence such that if local recurrence rate
is reduced by 20% from 30% to 10% then breast cancer
mortality is reduced by only 4%.6 This suggests that
metastasis by the conventional model may account
for only about a fifth of the metastatic process and
the alternative model may explain the remaining
fourth-fifth.
(7) The hazards of relapse peak at a fixed time after exci-
sion of the ‘‘primary’’ tumour.7 In the conventional
model if tumour starts in the breast and spreads to
form metastasis, then the longer it has been in the
body (and larger it is), longer would the metastasis
have had to start growing. So a larger tumour should
have metastasis developing sooner and smaller ones
later. Thus the hazard of relapse should have peaked
earlier in a larger tumour and later for an ‘‘early’’ can-
cer. But in reality it is not the case, in both cases,
metastasis appear at the same time whatever the size
of the tumour e they just have a higher risk of occurring
in larger tumours e because again, the more disturbed
is the milieu, the larger is the tumour and higher is the
risk of appearance of relapse elsewhere. Perhaps the
act of surgery disturbs the internal milieu even more
and allows the cancer stem cells from rest of the
body to grow, thus the duration between surgery and
hazard-peak is constant irrespective of the size of the
‘‘primary’’ tumour in the breast.
(8) Systemic chemotherapy that is shown to work very well
in ‘‘killing’’ cancer cells has only a modest effect on
mortality8 and offers almost no survival benefit in
metastatic disease.9 This is because it is designed to
kill the already malignant cells and not to restore the
internal milieu. It works well for haematological
Peer Reviewed 75malignancies perhaps because it depletes the sensitive
haematopoietic stem cells themselves. High-dose che-
motherapy with stem cell harvest does not work despite
achieving ‘‘complete response’’ perhaps because of the
stem cells that rescue the patient as well as the cancer.
There is growing interest in the cancer stem cell. This is
supposed to be less sensitive to current chemotherapy
and its characterisation today has the obvious aim of
better targeting this cell to cure cancer. Although
therapies that are targeted to kill tumour cells or
even cancer stem cells will work, the effect is still
only modest. In addition the solid organ stem cells
may have many other functions that are vital to its
function and killing them may be more disastrous than
killing haematopoietic stem cells. And even then,
many patients would ‘‘recur’’ because the fundamental
problem of faulty milieu is not solved.
‘‘Disturbance of internal milieu’’ is a very broad
concept and I have not attempted a description of its
complexity here. Disturbances of this milieu could be
simple factor either genetically driven or environmental e
from BRCA gene mutations to tobacco smoking, or,
hormonal such as increasing exposure to continuous
cycling of female hormones or early abortion of the full
pituitaryemammary axis by not breast feeding, or direct
effect on immunity such as AIDS, treatment of childhood
leukaemia or cyclosporine given for transplantation. It
could also be more complex and need not always be
extracellular. The PTEN (phosphate and tensin homologue)
protein is a tumour suppressor and intracellular modulator
of several major cell signalling pathways. It appears
that11,12 PTEN via the PI3K/PTEN/AKT pathway, is critical
component of a molecular switch that modulates the be-
haviour of stem cells e whether they remain quiescent,
self renew, and create differentiating cells, or produce
cancer stem cells that ultimately give rise to a tumour.
With a conventional perspective, as has been followed
by these authors11,12 we have now found a new way to
kill cancer stem cells while preserving normal stem cells.
With the novel perspective on the other hand, one would
think ‘‘why does the PTEN not work properly in the
patient with the tumour’’. Why did the Pten gene get
mutated? We need to aim to repair that fundamental
mechanism and not just try to repair the Pten gene or
its products so that homeostasis can be restored. The
mechanistic solution of the conventional model could be
by substitution, albeit partially with rapamycin, that
inhibits the AKT effector mTOR and restores normal stem
cells and depletes cancer stem cells. This approach may
well work e but at certain point will hit a ceiling. Ideally
we need to find ways of keeping this PI3K/PTEN/AKT
machinery (and other ones) intact on a continuous basis.
Rather than only killing of the rogue cells or patching up
the rogue pathways, we need to find and repair or
restore that which makes them rogue.
The transfection theory10 suggests that mutated genetic
material from the primary tumour cells could be trans-
ferred to normal differentiated host cells by the process
of transfection via the cells of the reticuloendothelial
(RE) system. This could be an example of a mechanism of
disturbance of internal milieu, in this case the RE system.Looking at a wrecked car in isolation, without the
knowledge of the road conditions and the recently
attended party cannot tell us how it wrecked although
alcohol level in the blood of the driver and the snow on the
bonnet may give us a clue, but only if we think about it.
This paper is aimed only to suggest an alternative
perspective of natural history of solid tumours e to
stimulate research on the complex internal milieu that
allows the cancer cell to develop in new light. In the history
of science, it is the change in perspective that has usually
been the most important.
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